ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
265 Endocrine effects of low dose aminoglutethimide without hydrocortisone in breast cancer patients
Journal of Steroid Biochemistry
◽
10.1016/0022-4731(83)91765-x
◽
1983
◽
Vol 19
◽
pp. 88
Author(s):
R. Stuart-Harris
◽
M. Dowsett
◽
A. D'Souza
◽
S.L. Jeffcoate
◽
I.E. Smith
Keyword(s):
Breast Cancer
◽
Cancer Patients
◽
Low Dose
◽
Breast Cancer Patients
◽
Endocrine Effects
Download Full-text
Related Documents
Cited By
References
A comparison of the endocrine effects of low dose aminoglutethimide with and without hydrocortisone in postmenopausal breast cancer patients
British Journal of Cancer
◽
10.1038/bjc.1985.223
◽
1985
◽
Vol 52
(4)
◽
pp. 525-529
◽
Cited By ~ 33
Author(s):
M Dowsett
◽
A L Harris
◽
R Stuart-Harris
◽
M Hill
◽
B M Cantwell
◽
...
Keyword(s):
Breast Cancer
◽
Cancer Patients
◽
Low Dose
◽
Postmenopausal Breast Cancer
◽
Breast Cancer Patients
◽
Endocrine Effects
Download Full-text
Effective inhibition by low dose aminoglutethimide of peripheral aromatization in postmenopausal breast cancer patients
British Journal of Cancer
◽
10.1038/bjc.1985.144
◽
1985
◽
Vol 52
(1)
◽
pp. 31-35
◽
Cited By ~ 22
Author(s):
M Dowsett
◽
S J Santner
◽
R J Santen
◽
S L Jeffcoate
◽
I E Smith
Keyword(s):
Breast Cancer
◽
Cancer Patients
◽
Low Dose
◽
Postmenopausal Breast Cancer
◽
Breast Cancer Patients
◽
Effective Inhibition
Download Full-text
In vivo manipulation of Vγ9Vδ2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients
Clinical & Experimental Immunology
◽
10.1111/j.1365-2249.2010.04167.x
◽
2010
◽
pp. no-no
◽
Cited By ~ 52
Author(s):
S. Meraviglia
◽
M. Eberl
◽
D. Vermijlen
◽
M. Todaro
◽
S. Buccheri
◽
...
Keyword(s):
Breast Cancer
◽
T Cells
◽
Advanced Breast Cancer
◽
Cancer Patients
◽
Low Dose
◽
Interleukin 2
◽
Advanced Breast
◽
Breast Cancer Patients
◽
Vγ9vδ2 T Cells
Download Full-text
Alterations in p53-specific T cells and other lymphocyte subsets in breast cancer patients during vaccination with p53-peptide loaded dendritic cells and low-dose interleukin-2
Vaccine
◽
10.1016/j.vaccine.2008.06.085
◽
2008
◽
Vol 26
(36)
◽
pp. 4716-4724
◽
Cited By ~ 19
Author(s):
Inge Marie Svane
◽
Anders E. Pedersen
◽
Kirsten Nikolajsen
◽
Mai-Britt Zocca
Keyword(s):
Breast Cancer
◽
T Cells
◽
Dendritic Cells
◽
Cancer Patients
◽
Low Dose
◽
Lymphocyte Subsets
◽
Interleukin 2
◽
Breast Cancer Patients
Download Full-text
The endocrine effects of bromocriptine and SMS 201–995 in advanced breast cancer patients
European Journal of Cancer and Clinical Oncology
◽
10.1016/0277-5379(90)90412-m
◽
1990
◽
Vol 26
(2)
◽
pp. 176
Keyword(s):
Breast Cancer
◽
Advanced Breast Cancer
◽
Cancer Patients
◽
Advanced Breast
◽
Breast Cancer Patients
◽
Endocrine Effects
Download Full-text
Endocrine effects of adjuvant letrozole versus tamoxifen in hormone responsive postmenopausal early breast cancer patients: results from the HOBOE randomized trial.
10.1158/0008-5472.sabcs-1150
◽
2009
◽
Author(s):
A Morabito
◽
E Rossi
◽
F Di Rella
◽
G Esposito
◽
A Gravina
◽
...
Keyword(s):
Breast Cancer
◽
Randomized Trial
◽
Cancer Patients
◽
Early Breast Cancer
◽
Breast Cancer Patients
◽
Endocrine Effects
Download Full-text
Abstract P5-04-29: Efficacy and safety of low-dose everolimus in Chinese HR-positive, HER2-negative metastatic breast cancer patients
10.1158/1538-7445.sabcs18-p5-04-29
◽
2019
◽
Author(s):
X Shao
◽
X Wang
◽
Z Chen
◽
Y Zheng
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Cancer Patients
◽
Low Dose
◽
Metastatic Breast
◽
Efficacy And Safety
◽
Breast Cancer Patients
Download Full-text
P215 Phase II study with S-1 + low dose docetaxel (N-1 study) for operable breast cancer patients
The Breast
◽
10.1016/s0960-9776(15)70249-3
◽
2015
◽
Vol 24
◽
pp. S99-S100
Author(s):
Y. Tadokoro
◽
M. Morimoto
◽
M. Nakagawa
◽
H. Takechi
◽
A. Tangoku
Keyword(s):
Breast Cancer
◽
Cancer Patients
◽
Phase Ii
◽
Low Dose
◽
Phase Ii Study
◽
Operable Breast Cancer
◽
Breast Cancer Patients
Download Full-text
Tailored low-dose gemcitabine-cisplatin combination is a feasible and effective treatment in heavily pretreated advanced breast cancer patients
Journal of Clinical Oncology
◽
10.1200/jco.2005.23.16_suppl.837
◽
2005
◽
Vol 23
(16_suppl)
◽
pp. 837-837
◽
Cited By ~ 1
Author(s):
J. E. Alés-Martínez
◽
S. Hernández
◽
R. Sánchez-Escribano
◽
P. Aramburo
Keyword(s):
Breast Cancer
◽
Advanced Breast Cancer
◽
Effective Treatment
◽
Cancer Patients
◽
Low Dose
◽
Advanced Breast
◽
Breast Cancer Patients
◽
Heavily Pretreated
Download Full-text
Influence of low-dose beta-interferon on natural killer cell activity in breast cancer patients subjected to chemotherapy
Cancer Immunology Immunotherapy
◽
10.1007/bf00199838
◽
1987
◽
Vol 24
(1)
◽
pp. 86-91
◽
Cited By ~ 7
Author(s):
Lucio Tentori
◽
Maria Pia Fuggetta
◽
Stefania D'Atri
◽
Angelo Aquino
◽
Corrado Nunziata
◽
...
Keyword(s):
Breast Cancer
◽
Natural Killer Cell
◽
Natural Killer
◽
Cancer Patients
◽
Low Dose
◽
Natural Killer Cell Activity
◽
Killer Cell
◽
Cell Activity
◽
Breast Cancer Patients
◽
Killer Cell Activity
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close